Merck’s animal health division, formerly known as Intervet/Schering-Plough Animal Health, announced today it will begin using the name, Merck Animal Health. It will be known as MSD Animal Health outside the U.S. and Canada.
Merck Animal Health is a global company focusing on research, development, manufacturing and sale of veterinary medication and vaccines. The division generated global sales of $2.9 billion in 2010.
“The name change reflects Merck’s commitment to animal health and its complementary role to the overall business,” says Raul Kohan, president of Merck Animal Health. “We are unwavering in our commitment to veterinarians, producers, pet owners and society as a whole. We aim to generate additional value and sustained growth by continuing to provide integrated solutions with innovative animal health products and services to meet the evolving needs of our customers.”
This change follows the March announcement by Merck and sanofi-aventis ending plans to form an animal health joint venture.
“With the scientific and business backing of Merck, Merck Animal Health possesses the necessary mix of resources to enhance our position as an industry leader,” Kohan says.